NF-κB in biology and targeted therapy: new insights and translational implications

Q Guo, Y **, X Chen, X Ye, X Shen, M Lin… - Signal transduction and …, 2024 - nature.com
NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was
identified as a pivotal pathway in mediating inflammatory responses. However, with …

Resolution of inflammation: An organizing principle in biology and medicine

D Panigrahy, MM Gilligan, CN Serhan… - Pharmacology & …, 2021 - Elsevier
The resolution of inflammation has emerged as a critical endogenous process that protects
host tissues from prolonged or excessive inflammation that can become chronic. Failure of …

Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach

G Targher, H Tilg, CD Byrne - The lancet Gastroenterology & …, 2021 - thelancet.com
Non-alcoholic fatty liver disease (NAFLD) is a public health problem worldwide. This
narrative Review provides an overview of the current literature to support the notion that …

Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy

ED Smith, NK Lakdawala, N Papoutsidakis, G Aubert… - Circulation, 2020 - ahajournals.org
Background: Mutations in desmoplakin (DSP), the primary force transducer between cardiac
desmosomes and intermediate filaments, cause an arrhythmogenic form of cardiomyopathy …

NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy

SP Chelko, VR Penna, M Engel, EA Shiel… - The Journal of clinical …, 2024 - jci.org
Nuclear factor κ-B (NFκB) is activated in iPSC-cardiac myocytes from patients with
arrhythmogenic cardiomyopathy (ACM) under basal conditions, and inhibition of NFκB …

Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy

D Harding, MHA Chong, N Lahoti… - Journal of internal …, 2023 - Wiley Online Library
Dilated cardiomyopathy (DCM) is typically defined by left ventricular dilation and systolic
dysfunction in the absence of a clear precipitant. Idiopathic disease is common; up to 50% of …

Carcinogenesis: Failure of resolution of inflammation?

A Fishbein, BD Hammock, CN Serhan… - Pharmacology & …, 2021 - Elsevier
Inflammation in the tumor microenvironment is a hallmark of cancer and is recognized as a
key characteristic of carcinogens. However, the failure of resolution of inflammation in …

AAV9:PKP2 improves heart function and survival in a Pkp2-deficient mouse model of arrhythmogenic right ventricular cardiomyopathy

I Wu, A Zeng, A Greer-Short, JA Aycinena… - Communications …, 2024 - nature.com
Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a familial cardiac
disease associated with ventricular arrhythmias and an increased risk of sudden cardiac …

Inflammation and immune response in arrhythmogenic cardiomyopathy: state-of-the-art review

B Asatryan, A Asimaki, AP Landstrom, MY Khanji… - Circulation, 2021 - ahajournals.org
Arrhythmogenic cardiomyopathy (ACM) is a primary disease of the myocardium,
predominantly caused by genetic defects in proteins of the cardiac intercalated disc …

Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration

J Cadrin-Tourigny, LP Bosman, W Wang… - Circulation …, 2021 - ahajournals.org
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with
ventricular arrhythmias (VA) and sudden cardiac death (SCD). A model was recently …